このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effect of Cordyceps Supplementation Timing on Physiological Responses and Aerobic Adaptation in Athletes (CORD-RECOV)

2026年8月21日 更新者:Bayu Agung Pramono、Surabaya State University

Optimization of Athlete Recovery: Effects of Cordyceps Supplementation Timing on Inflammatory Response, Oxidative Stress, Muscle Damage, and Aerobic Adaptation Following Acute and Chronic Exercise Training

Athletes frequently perform high-intensity exercise to improve physical performance and aerobic capacity. However, such training can induce exercise-induced muscle damage, oxidative stress, and inflammatory responses that may delay recovery and compromise subsequent training adaptations. Optimizing recovery strategies is therefore essential to maintain performance, reduce injury risk, and support long-term athletic development.

Cordyceps is a medicinal mushroom that contains several bioactive compounds, including cordycepin and polysaccharides, which have demonstrated antioxidant, anti-inflammatory, and immunomodulatory properties. Although previous studies have reported beneficial effects of Cordyceps supplementation on exercise performance and physiological function, limited evidence exists regarding the optimal timing of supplementation relative to exercise.

This study aims to investigate the effects of different Cordyceps supplementation timing strategies on physiological responses and aerobic adaptation following acute and chronic exercise training. Participants will be assigned to receive Cordyceps supplementation before exercise, after exercise, or placebo. The study will evaluate biomarkers of inflammation (IL-6), oxidative stress (MDA), muscle damage (CK), aerobic capacity (VO2max), and neuromuscular performance assessed using countermovement jump (CMJ) testing.

The findings of this study are expected to provide evidence-based recommendations regarding nutritional recovery strategies and supplementation timing to optimize recovery and training adaptation in athletes and physically active individuals.

調査の概要

詳細な説明

Background

Recovery is a fundamental component of the training process because physiological adaptation occurs not only during exercise but also during the recovery period following exercise-induced stress. High-intensity exercise is widely used to improve athletic performance and aerobic capacity; however, it is also associated with increased physiological stress, including exercise-induced muscle damage (EIMD), oxidative stress, and inflammatory responses. Excessive accumulation of these responses may impair recovery, reduce training quality, increase injury risk, and contribute to non-functional overreaching or overtraining.

Exercise-induced physiological stress is commonly characterized by elevations in inflammatory biomarkers such as interleukin-6 (IL-6), muscle damage markers such as creatine kinase (CK), and oxidative stress markers such as malondialdehyde (MDA). Conversely, appropriate recovery interventions may facilitate restoration of physiological homeostasis and support positive training adaptations, including improvements in aerobic capacity.

Cordyceps is a medicinal fungus that contains several biologically active compounds, including cordycepin, polysaccharides, nucleosides, sterols, and phenolic compounds. Experimental and clinical studies have demonstrated antioxidant, anti-inflammatory, and immunomodulatory properties of Cordyceps. These mechanisms suggest that Cordyceps supplementation may help attenuate exercise-induced physiological stress while supporting recovery and adaptation processes.

Despite increasing interest in Cordyceps supplementation among athletes, evidence regarding the influence of supplementation timing remains limited. Most previous studies have focused primarily on supplementation efficacy without specifically evaluating whether administration before exercise or after exercise produces differential physiological effects. Understanding the role of supplementation timing may contribute to the development of more effective recovery strategies in sports science.

Objectives

The primary objective of this study is to evaluate the effects of Cordyceps supplementation timing on exercise-induced physiological responses and aerobic adaptation following acute and chronic exercise training.

Specific objectives include:

  1. To compare the effects of pre-exercise and post-exercise Cordyceps supplementation on inflammatory response, muscle damage, and oxidative stress following acute exercise.
  2. To compare the effects of pre-exercise and post-exercise Cordyceps supplementation on inflammatory response, muscle damage, oxidative stress, and aerobic capacity following chronic exercise training.
  3. To compare physiological responses among pre-exercise supplementation, post-exercise supplementation, and placebo groups.
  4. To evaluate the interaction between supplementation timing and exercise exposure on selected physiological biomarkers.
  5. To investigate the relationship between changes in oxidative stress, muscle damage, and aerobic adaptation.

Study Rationale

The scientific rationale of this study is based on the hypothesis that the timing of nutrient delivery may influence physiological responses to exercise. Supplementation administered before exercise may enhance physiological preparedness and reduce exercise-induced stress, whereas supplementation administered after exercise may facilitate recovery and tissue regeneration processes. Identifying the optimal timing strategy may improve recovery efficiency and maximize training adaptation.

Study Outcomes

The study will evaluate biomarkers associated with inflammation, oxidative stress, and muscle damage, including IL-6, MDA, and CK. Aerobic adaptation will be assessed through maximal oxygen uptake (VO2max). In addition to biochemical markers and aerobic capacity, neuromuscular performance will be assessed using countermovement jump (CMJ) testing performed on a validated VALD system. CMJ variables will be used to evaluate lower-body power output and neuromuscular recovery status following acute and chronic exercise exposure.

Potential Significance

This study is expected to generate novel evidence regarding the role of Cordyceps supplementation timing in athletic recovery and adaptation. The findings may support the development of evidence-based nutritional strategies for athletes, coaches, sports scientists, and healthcare professionals. Furthermore, the study may contribute to a better understanding of the relationship between oxidative stress, inflammation, muscle damage, and aerobic adaptation during exercise training.

研究の種類

介入

入学 (実際)

30

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Jawa Timur - East Java
      • Surabaya、Jawa Timur - East Java、インドネシア、60213
        • Faculty of Sport and Health Sciences

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Male participants aged 19-21 years.
  • Students enrolled in the Sport Coaching Education Program (Pendidikan Kepelatihan Olahraga).
  • Apparently healthy and free from known cardiovascular, metabolic, respiratory, neuromuscular, or musculoskeletal disorders that could affect participation in exercise training.
  • Regularly participate in physical exercise at least three times per week during the previous three months.
  • Willing to comply with all study procedures, exercise protocols, supplementation schedules, and assessment sessions.
  • Provide written informed consent before participation.

Exclusion Criteria:

  • Current injury or musculoskeletal condition that limits participation in exercise training.
  • History of cardiovascular disease, uncontrolled hypertension, diabetes mellitus, respiratory disease, or other medical conditions that may increase exercise-related risk.
  • Use of antioxidant supplements, herbal supplements, ergogenic aids, or anti-inflammatory medications within four weeks prior to study enrollment.
  • Known allergy or hypersensitivity to Cordyceps or any component of the study supplements.
  • Smoking or excessive alcohol consumption during the study period.
  • Failure to comply with supplementation or exercise protocols.
  • Participation in another research study during the study period.
  • Participants presenting acute infection, fever, or inflammatory conditions within two weeks prior to baseline assessment.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Pre-Exercise Cordyceps
Participants receive Cordyceps supplementation twice prior to exercise sessions, with administration occurring approximately 11 hours and 1 hour before exercise. This intervention is designed to evaluate the effects of pre-exercise supplementation timing on inflammatory response, oxidative stress, muscle damage, neuromuscular performance, and aerobic adaptation following acute and chronic exercise training.
Participants in the pre-exercise group received 200 mg of a 10:1 Cordyceps sinensis CS-4 extract per administration (equivalent to 2,000 mg of raw Cordyceps material), with two capsules administered approximately 11 hours and 1 hour before each exercise session. Supplementation was provided three times per week for 4 weeks. The intervention is designed to evaluate the effects of pre-exercise supplementation timing on inflammatory response (IL-6), oxidative stress (MDA), muscle damage (CK), countermovement jump (CMJ) performance, and aerobic adaptation (VO2max).
他の名前:
  • cordyceps
実験的:Post-Exercise Cordyceps
Participants receive Cordyceps supplementation immediately after completion of each exercise session. This intervention is designed to evaluate the effects of post-exercise supplementation timing on physiological recovery, neuromuscular performance, and aerobic adaptation following acute and chronic exercise training.
Participants in the post-exercise group received 200 mg of a 10:1 Cordyceps sinensis CS-4 extract (equivalent to 2,000 mg of raw Cordyceps material; two capsules) immediately after each exercise session, three times per week for 4 weeks. The intervention is designed to evaluate the effects of post-exercise supplementation timing on inflammatory response (IL-6), oxidative stress (MDA), muscle damage (CK), countermovement jump (CMJ) performance, and aerobic adaptation (VO2max).
他の名前:
  • Cordyceps
プラセボコンパレーター:Placebo
Participants receive placebo capsules matched in appearance and administration schedule to the Cordyceps supplementation groups. The placebo group serves as the control condition for comparison of physiological and performance outcomes.
Participants received two placebo capsules immediately after each exercise session, three times per week for 4 weeks. The placebo capsules contained the same excipient base without Cordyceps sinensis extract and were identical to the active capsules in appearance, size, packaging, and administration procedure to maintain blinding. and serves as the control condition for comparison of physiological and performance outcomes.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Interleukin-6 (IL-6)
時間枠:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum interleukin-6 (IL-6) concentration measured as a biomarker of exercise-induced inflammatory response following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Creatine Kinase (CK)
時間枠:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum creatine kinase (CK) concentration measured as a biomarker of exercise-induced muscle damage following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Malondialdehyde (MDA)
時間枠:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Serum malondialdehyde (MDA) concentration measured as a biomarker of oxidative stress following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Maximal Oxygen Uptake (VO2max)
時間枠:Baseline and after 4 weeks of chronic exercise training.
Maximal oxygen uptake (VO2max) assessed as an indicator of aerobic capacity and chronic training adaptation.
Baseline and after 4 weeks of chronic exercise training.

二次結果の測定

結果測定
メジャーの説明
時間枠
Countermovement Jump (CMJ) Performance
時間枠:Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.
Countermovement jump performance assessed using the VALD ForceDecks system as an indicator of neuromuscular function and recovery following acute and chronic exercise training.
Baseline, 1 hour, 24 hours, and 48 hours following acute exercise; baseline and after 4 weeks of chronic exercise training with measurements obtained at 1 hour, 24 hours, and 48 hours following the final training session.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Nining W Kusnanik, Dr.、Surabaya State University
  • スタディディレクター:Agus Hariyanto, Dr.、Surabaya State University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年6月9日

一次修了 (実際)

2026年8月1日

研究の完了 (実際)

2026年8月10日

試験登録日

最初に提出

2026年6月17日

QC基準を満たした最初の提出物

2026年6月17日

最初の投稿 (実際)

2026年6月24日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月25日

QC基準を満たした最後の更新が送信されました

2026年8月21日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Individual participant data (IPD) that underlie the results reported in publications, after de-identification, will be made available to qualified researchers upon reasonable request. Data sharing will be permitted for scientifically sound research purposes following publication of the primary study results. Requests for access to the data will be reviewed by the principal investigator and must comply with institutional and ethical requirements. Supporting documents, including the study protocol and statistical analysis plan, may also be made available upon request.

IPD 共有時間枠

Individual participant data (IPD), study protocol, and statistical analysis plan will be available beginning after publication of the primary and secondary study results and will remain available for 5 years thereafter.

IPD 共有アクセス基準

De-identified individual participant data (IPD), study protocol, and statistical analysis plan will be available to qualified researchers upon reasonable request. Access requests must include a scientifically sound research proposal and the intended use of the data. Requests will be reviewed by the principal investigator to ensure compliance with ethical, legal, and institutional requirements. Approved researchers will be granted access to the relevant data and supporting documents through direct communication with the principal investigator and, when appropriate, under a data-sharing agreement.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP

試験データ・資料

  1. 研究プロトコル
    情報識別子:PROTOCOL-2026
    情報コメント:The study protocol will be available upon reasonable request to the principal investigator following publication of the primary and secondary study results.
  2. 統計分析計画
    情報識別子:SAP-2026
    情報コメント:The statistical analysis plan will be available upon reasonable request to qualified researchers following publication of the primary and secondary study results

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する